Drug intelligence / Profile preview

HMW1 + HMW2

Development stage
Preclinical
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Subcutaneous, Intranasal
01

Overview

HMW1 + HMW2 is an experimental **protein subunit vaccine antigen combination** comprising the nontypeable *Haemophilus influenzae* high-molecular-weight adhesins HMW1 and HMW2. These surface-exposed bacterial adhesins are major colonization factors and vaccine-candidate antigens intended to induce antibodies that block adherence of nontypeable *H. influenzae* to respiratory epithelium, promote bacterial agglutination and opsonophagocytic killing, and thereby reduce nasopharyngeal colonization and subsequent respiratory disease. The combination has been investigated in preclinical studies, including recombinant protein immunization and adenoviral expression approaches, as a candidate vaccine strategy for prevention of infections caused by nontypeable *H. influenzae*, which is implicated in otitis media and exacerbations of chronic obstructive pulmonary disease.

Other names
HMW1 + HMW2high-molecular-weight adhesin 1 + high-molecular-weight adhesin 2
02

Targets

HMW1 (High-molecular-weight adhesin 1)HMW2 (High-molecular-weight adhesin 2)

Beyond the preview

Go deeper on HMW1 + HMW2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HMW1 + HMW2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call